News
Updates to Requirements for Buprenorphine Prescribing
In January 2023, SAMHSA announced that clinicians no longer need a federal waiver to prescribe buprenorphine for treating opioid use disorder. However, clinicians are still required to register with the Drug Enforcement Agency to prescribe …
May 18, 2023New Research Publications Highlight NIATx Versatility
Recent projects have used the NIATx approach to explore coaching, how patients use mobile health apps, and how to recruit prescribers for medications for opioid use disorder (MOUD). Coaching as an implementation strategy What makes …
February 27, 2023Using the Cascade of Care to Increase Medications for Opioid Use Disorder in CJ Settings
The opioid epidemic has had a disproportionate impact on the nation’s criminal justice (CJ) population. Justice-involved individuals with opioid use disorders (OUD) desperately need evidence-based translational practices to implement medication for opioid use disorder (MOUD), …
November 16, 2021NIATx project explores reducing no-shows in dental settings
The NIATx Dental Pilot study tested using the NIATx model for organizational change to reduce appointment no-shows in dental care settings. The NIATx model was applied through a multisite learning collaborative that engaged participating organizations …
July 16, 2021NIATx Project Improves Transitions from OUD Withdrawal to Continuing Care
The LINK system integrates three evidence-based implementation science approaches: (a) practice bundle, (b) process checklist, and (c) standardized organizational change model (NIATx). This integrated implementation approach improved withdrawal management to continuing care transition rates from …
July 15, 2021- More News